| GF | Growth factor |
| PAMPs | Pathogen-associated molecular patterns |
| NO | Nitric oxide |
| PGI2 | Prostacyclin |
| vWF | Von Willebrand factor |
| GP | Glycoprotein |
| ADP | Adenosine diphosphate |
| TxA2 | Thromboxane A2 |
| VEGF | Vascular endothelial growth factor |
| FGF | Fibroblast growth factor |
| PDGF | Platelet derived growth factor |
| MMP | Matrix metalloproteinase |
| EMT | Epithelial-mesenchymal transition |
| PF | Platelet factor |
| RANTES | Regulated upon activation, normal T cell expressed and presumably secreted |
| IL | Interleukin |
| EGF | Epidermal growth factor |
| HGF | Hepatocyte growth factor |
| TGF-β | Transforming growth factor β |
| CXCL | C-X-C motif chemokine ligand |
| SDF-1α | Stromal derived factor 1α |
| CCL | C-C motif chemokine ligand |
| MCP | Monocyte chemoattractant protein |
| CD | Cluster of differentiation |
| TLT-1 | TREM-like transcript 1 |
| Ig | Immunoglobulin |
| PAI-1 | Plasminogen activator inhibitor 1 |
| TFPI | Tissue factor pathway inhibitor |
| ATP | Adenosine triphosphate |
| GTP | Guanosine triphosphate |
| GDP | Guanosine diphosphate |
| CVD | Cardiovascular disease |
| LDL | Low-density lipoprotein |
| ROS | Reactive oxygen species |
| WDR1 | WD repeat protein 1 |
| PDE3A | Phosphodiesterase 3A |
| cAMP | Cyclic adenosine monophosphate |
| SMC | Smooth muscle cell |
| SFKs | Src family kinases |
| MPs | Microparticles |
| MiRNA | MicroRNA |
| ACS | Acute coronary syndrome |
| VCAM-1 | Vascular cell adhesion molecule 1 |
| ICAM-1 | Intercellular adhesion molecule 1 |
| CXCR | C-X-C Motif Chemokine Receptor |
| MRP | Myeloid-related protein |
| PAFR | Platelet-activating factor receptor |
| LEPRL | Leptin activates long-form leptin receptor |
| JAK2 | Janus kinase 2 |
| PI3K | Phosphatidylinositol 3-kinase |
| PKB | Protein kinase B |
| IRS-1 | Insulin receptor substrate-1 |
| PLA | Platelet-leukocyte aggregation |
| ASA | Acetylsalicylic acid |
| DM | Diabetes mellitus |
| PKC | Protein kinase C |
| TNF-α | Tumor necrosis factor α |
| T2DM | Type 2 diabetes mellitus |
| Mac-1 | Macrophage antigen 1 |
| PRP | Platelet Rich Plasma |
| VEGFR | Vascular endothelial growth factor receptor |
| PEDF | Pigment epithelium-derived factor |
| DIC | Disseminated intravascular coagulation |
| NETs | Neutrophil extracellular traps |
| TLRs | Toll-like receptors |
| β-TG | β-thromboglobulin |
| SrpA | Serine-rich protein A |
| RGD | Arginine–glycine–aspartic acid |
| Clf | Clumping factors |
| TFPI | Cyclooxygenase-1 |
| SIRS | Systemic inflammatory response syndrome |
| DAMPs | Damage-related molecular patterns |
| PSGL-1 | P-selectin glycoprotein ligand-1 |
| PAF | Platelet activating factor |
| MS | Multiple sclerosis |
| AD | Alzheimer’s disease |
| mTOR | Mammalian target of rapamycin |
| MAPK | Mitogen-activated protein kinase |
| CANTOS | Canakinumab anti-inflammatory thrombosis outcome study |
| DC | Dendritic cell |
| CLEC-2 | C-type lectin-like receptor II-type |
| MHC | Major histocompatibility complex |
| CNS | Central nervous system |
| BBB | Blood-brain barrier |
| EAE | Experimentally induced autoimmune encephalomyelitis |
| CSF | Cerebrospinal fluid |
| PSD95 | Postsynaptic density protein95 |
| CVT | Cerebral venous thrombosis |
| tMCAO | Transient middle cerebral artery occlusion |
| MPV | Mean platelet volume |
| DSCG | Disodium cromoglycate |
| G-CSF | Granulocyte colony-stimulating factor |
| GM-CSF | Granulocyte-macrophage colony-stimulating factors |
| RhoA | Ras homolog family member A |
| MYPT1 | Myosin phosphatase target subunit 1 |
| PP1 | Protein phosphatase 1 |
| YAP 1 | Yes-associated protein 1 |
| SMAD | Suppressor of Mothers Against Decapentaplegic |
| NF-kB | Nuclear factor kappa B |
| COVID-19 | Coronavirus disease 2019 |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |
| ITAM | Immunoreceptor tyrosine-based activation motif |
| ITP | Immune thrombocytopenia |
| IVIg | Gamma globulin intravenous infusion |
| rhTPO | Recombinant human thrombopoietin |